RIGScan CR49
RIGScan CR49 Uses, Dosage, Side Effects, Food Interaction and all others data.
RIGScan CR49, a 125I-labelled CR monoclonal antibody directed against the tumour-associated antigen TAG-72, is undergoing development with Neoprobe for the intraoperative detection of metastatic colorectal cancer.
| Trade Name | RIGScan CR49 |
| Generic | NAV 1800 |
| NAV 1800 Other Names | RIGScan CR, RIGScan CR49 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Uses
Investigated for use/treatment in colorectal cancer and solid tumors.
How RIGScan CR49 works
RIGScan CR49 is used to locate cancerous tissue during surgery for patients with metastatic cancer of the colon or rectum (colorectal). In multicenter Phase II and pivotal Phase III clinical trials, RIGScan CR49 located tumor confirmed by pathology tests in 90 percent of evaluable patients who participated in the studies. The product found pathology-confirmed tumor that was missed by the surgeon and by preoperative diagnostic scans in one of five of the evaluable patients.
Innovators Monograph
You find simplified version here RIGScan CR49
